Pliant Therapeutics
Price & Volume
Stats
See more52W Range | $10.22-$18 |
Market Cap | $727.2M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.35 |
News
See moreYahoo Finance • 16 days ago
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last year
Pliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing Cholangitis
Yahoo Finance • last year
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Yahoo Finance • last year
Pliant Therapeutics to Participate in Upcoming Investor Conferences
About
CEO | Dr. Bernard Coulie M.B.A., M.D., Ph.D. |
Address | 260 Littlefield Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 166 |
